These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32817238)

  • 21. Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.
    Veiga-Canuto D; Cifrián-Pérez M; Pitarch-Castellano I; Vázquez-Costa JF; Aparici F
    Eur J Neurol; 2021 Feb; 28(2):676-680. PubMed ID: 33051940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound assisted lumbar intrathecal administration of nusinersen in adult patients with spinal muscular atrophy: A case series.
    Zanfini BA; Catarci S; Patanella AK; Pane M; Frassanito L; Filipponi E; Mercuri E; Sabatelli M; Draisci G
    Muscle Nerve; 2021 Nov; 64(5):594-599. PubMed ID: 34396547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cone-beam computed tomography guided nusinersen administrations in adult spinal muscular atrophy patients with challenging access: a single- center experience.
    Salapura V; Snoj Z; Leonardis L; Koritnik B; Kostadinova V
    Radiol Oncol; 2022 Aug; 56(3):319-325. PubMed ID: 35962954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity. Feasibility, safety and radiation exposure considerations.
    Spiliopoulos S; Reppas L; Zompola C; Palaiodimou L; Papadopoulou M; Filippiadis D; Palialexis K; Ploussi A; Efstathopoulos E; Tsivgoulis G; Brountzos E
    Eur J Neurol; 2020 Jul; 27(7):1343-1349. PubMed ID: 32250518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach.
    Bortolani S; Stura G; Ventilii G; Vercelli L; Rolle E; Ricci F; Bergui M; Mongini T
    Neuromuscul Disord; 2019 Oct; 29(10):742-746. PubMed ID: 31604650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nusinersen for the treatment of spinal muscular atrophy.
    Chiriboga CA
    Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal Deformity.
    Papaliagkas V; Foroglou N; Toulios P; Moschou M; Gavriilaki M; Notas K; Chatzikyriakou E; Zafeiridou G; Arnaoutoglou M; Kimiskidis VK
    Case Rep Neurol; 2021; 13(3):710-715. PubMed ID: 34950009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nusinersen: A Treatment for Spinal Muscular Atrophy.
    Claborn MK; Stevens DL; Walker CK; Gildon BL
    Ann Pharmacother; 2019 Jan; 53(1):61-69. PubMed ID: 30008228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scoliosis Orthopedic Surgery Combined With Nusinersen Intrathecal Injection Significantly Improved the Outcome of Spinal Muscular Atrophy Patient: A Case Report.
    Xu B; Wei C; Hu X; Li W; Huang Z; Que C; Qiu J; Li C; Xiong H
    Front Neurol; 2022; 13():869230. PubMed ID: 35547367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of nusinersen via paramedian approach for spinal muscular atrophy.
    Iwayama H; Wakao N; Kurahashi H; Kubota N; Hattori A; Kumagai T; Okumura A
    Brain Dev; 2021 Jan; 43(1):121-126. PubMed ID: 32773161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal delivery of nusinersen in individuals with complicated spines.
    Cartwright MS; Ward ZT; White EP; West TG
    Muscle Nerve; 2020 Jul; 62(1):114-118. PubMed ID: 32319101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity.
    Nakao S; Yamada S; Tsuda K; Yokomizo T; Sato T; Tanoue S; Hiraki T
    JA Clin Rep; 2020 Apr; 6(1):28. PubMed ID: 32314319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.
    Stolte B; Totzeck A; Kizina K; Bolz S; Pietruck L; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
    Ther Adv Neurol Disord; 2018; 11():1756286418803246. PubMed ID: 30305849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful Combination of Neuraxial and Regional Anesthesia in a Child With Advanced Spinal Muscular Atrophy Type 1 Receiving Maintenance Nusinersen Therapy: A Case Report.
    Brown AF; Einhorn LM
    A A Pract; 2020 Apr; 14(6):e01206. PubMed ID: 32784322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: technical note and outcomes.
    Ko D; Blatt D; Karam C; Gupta K; Raslan AM
    J Neurosurg Spine; 2019 Aug; 31(2):217-221. PubMed ID: 31003222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nusinersen for Patients With Spinal Muscular Atrophy: 1415 Doses via an Interdisciplinary Institutional Approach.
    Madan E; Carrié S; Donado C; Lobo K; Souris M; Laine R; Beers E; Cornelissen L; Darras BT; Koka A; Riley B; Dinakar P; Stone S; Snyder B; Graham RJ; Padua H; Sethna N; Berde C
    Pediatr Neurol; 2022 Jul; 132():33-40. PubMed ID: 35636280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.
    Li Q
    Yonsei Med J; 2020 Apr; 61(4):273-283. PubMed ID: 32233169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen.
    Gingele S; Hümmert MW; Alvermann S; Jendretzky KF; Bönig L; Brieskorn M; Schwenkenbecher P; Sühs KW; Müschen LH; Osmanovic A; Schreiber-Katz O; Stangel M; Petri S; Skripuletz T
    Front Neurol; 2019; 10():735. PubMed ID: 31354609
    [No Abstract]   [Full Text] [Related]  

  • 39. Nusinersen treatment of spinal muscular atrophy - a systematic review.
    Albrechtsen SS; Born AP; Boesen MS
    Dan Med J; 2020 Aug; 67(9):. PubMed ID: 32800069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound-guided transforaminal approach for nusinersen delivery in adult spinal muscle atrophy patients with challenging access.
    Snoj Ž; Salapura V
    Muscle Nerve; 2022 May; 65(5):585-589. PubMed ID: 35147227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.